Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

EB-1020: Phase I data

October 22, 2012 7:00 AM UTC

A Phase I trial in about 50 healthy volunteers showed that single and multiple ascending-doses of EB-1020 were well tolerated. Neurovance plans to start Phase IIa testing of EB-1020 in mid-2013 with d...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article